OXFORD, United Kingdom, Aug. 09, 2023 (GLOBE NEWSWIRE) Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced the publication in Nature Communications of Evox-funded research
EVOX THERAPEUTICS LIMITED: Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics's proprietary exosome engineering platform finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
OXFORD, United Kingdom, Aug. 04, 2023 (GLOBE NEWSWIRE) Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced a research collaboration and option agreement with the Icahn
EVOX THERAPEUTICS LIMITED: Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
DGAP-News: Newron Pharmaceuticals S.p.A. / Key word(s): Half Year ReportNewron provides H1 2022 results and updates on R&D and business activities 15.09.2022 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Milan, Italy, September 15, 2022, 7 am CET – Newron Pharmaceuticals.